NTRA — Natera, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1604821 ·
Last close
$310.78
Market Cap
$44.80B
52W High
$326.03
52W Low
$184.81
ADV30
1,316,608
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 752,750,000 | 485,189,000 | -75,792,000 | -66,969,000 | 2,657,497,000 | 1,091,502,000 | 835,998,000 |
| Mar 2026 | 696,644,000 | 450,833,000 | -93,516,000 | -85,091,000 | 2,614,398,000 | 1,087,932,000 | 840,380,000 |
| Dec 2025 | 665,498,000 | 445,427,000 | -22,785,000 | 47,258,000 | 2,398,344,000 | 1,076,140,000 | 685,931,000 |
| Sep 2025 | 592,183,000 | 384,382,000 | -97,576,000 | -87,544,000 | 1,821,482,000 | 1,041,438,000 | 569,294,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$228,239,000
Investing CF
$-187,063,000
Financing CF
$50,305,000
CapEx
$-177,042,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.45
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,928,082,000
Inventory
$80,346,000
Receivables
$421,968,000
ST Investments
$0
EBIT TTM
$-248,883,000
Pretax Income TTM
$-252,701,000
Interest Exp TTM
$3,818,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,707,076,096
EBITDA
$-224,420,992
Free Cash Flow
$104,029,000
Enterprise Value
$44,690,776,064
Total Cash
$1,091,501,952
Total Debt
$238,488,000
Shares Out
144,144,170
Trailing EPS
$-1.36
Book Value
$12.43
ROE
-12.5%
ROA
-8.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,306,113,000 | -309,911,000 | -208,160,000 | 2,398,344,000 | 685,931,000 | — | 215,301,000 |
| Dec 2024 | 1,696,911,000 | -222,294,000 | -190,426,000 | 1,660,735,000 | 465,315,000 | — | 135,664,000 |
| Dec 2023 | 1,082,571,000 | -446,245,000 | -434,801,000 | 1,441,699,000 | 676,372,000 | — | -246,955,000 |
| Dec 2022 | 820,222,000 | -541,040,000 | -547,799,000 | 1,394,474,000 | 688,730,000 | — | -431,501,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.11
Max Pain — expiry 2026-08-21
max pain strike: $260.00 · spot: $310.78 · call oi: 9,900 · put oi: 6,924
Expected Move to 2026-08-21:
±$15.50
(4.99%) —
implied range
$295.28 –
$326.28
· ATM straddle on $310.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | $26.16B | $322.59 | — |
| DGX | QUEST DIAGNOSTICS INC | $26.05B | $236.04 | — |
| HCA | HCA Healthcare, Inc. | $91.34B | $411.74 | — |
| THC | TENET HEALTHCARE CORP | $21.50B | $267.05 | — |
| GH | Guardant Health, Inc. | $21.41B | $159.54 | — |
News headlines (Yahoo Finance, 1h cache)
Tempus AI's FDA Win Could Unlock Major Reimbursement Growth Ahead
2026-08-13 13:07 · Yahoo
Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High?
2026-08-12 14:55 · Yahoo
Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
2026-08-12 10:00 · Yahoo
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth
2026-08-11 14:13 · Yahoo
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
2026-08-10 22:31 · Yahoo
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
2026-08-10 22:21 · Yahoo
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
2026-08-10 22:09 · Yahoo
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It
2026-08-10 22:02 · Yahoo
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know
2026-08-10 21:54 · Yahoo
3 Growth Stocks with All-Star Potential
2026-08-10 15:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.